0 XP   0   0   0

Nyxoah
Buy, Hold or Sell?

Should you buy, hold or sell Nyxoah?

I guess you are interested in Nyxoah. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Nyxoah

Let's start. I'm going to help you getting a better view of Nyxoah. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Nyxoah even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Nyxoah is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Nyxoah. The closing price on 2023-01-30 was €5.09 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Nyxoah Daily Candlestick Chart
Nyxoah Daily Candlestick Chart
Summary









1. Valuation of Nyxoah




Current price per share

€5.09

2. Growth of Nyxoah




Is Nyxoah growing?

Current yearPrevious yearGrowGrow %
How rich?$144.4m$97.3m$55.2m36.2%

How much money is Nyxoah making?

Current yearPrevious yearGrowGrow %
Making money-$6.5m-$6.9m$361.3k5.5%
Net Profit Margin-1,773.9%-2,865.6%--

How much money comes from the company's main activities?

3. Financial Health of Nyxoah




Comparing to competitors in the Medical Instruments & Supplies industry




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#126 / 188

Most Revenue
#168 / 188

Most Profit
#150 / 188

Most Efficient
#183 / 188


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Nyxoah.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nyxoah earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -3,428.6% means that €-34.29 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nyxoah:

  • The MRQ is -3,428.6%. The company is making a huge loss. -2
  • The TTM is -1,773.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,428.6%TTM-1,773.9%-1,654.7%
TTM-1,773.9%YOY-2,865.6%+1,091.7%
TTM-1,773.9%5Y-1,546.5%-227.4%
5Y-1,546.5%10Y-1,546.5%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,428.6%7.5%-3,436.1%
TTM-1,773.9%7.3%-1,781.2%
YOY-2,865.6%8.7%-2,874.3%
5Y-1,546.5%6.8%-1,553.3%
10Y-1,546.5%7.0%-1,553.5%
1.1.2. Return on Assets

Shows how efficient Nyxoah is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • -3.8% Return on Assets means that Nyxoah generated €-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nyxoah:

  • The MRQ is -3.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-3.6%-0.2%
TTM-3.6%YOY-5.8%+2.2%
TTM-3.6%5Y-6.7%+3.1%
5Y-6.7%10Y-6.7%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%1.5%-5.3%
TTM-3.6%1.4%-5.0%
YOY-5.8%1.5%-7.3%
5Y-6.7%1.2%-7.9%
10Y-6.7%1.3%-8.0%
1.1.3. Return on Equity

Shows how efficient Nyxoah is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • -4.7% Return on Equity means Nyxoah generated €-0.05 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nyxoah:

  • The MRQ is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-4.3%-0.4%
TTM-4.3%YOY-7.2%+2.9%
TTM-4.3%5Y-15.2%+10.9%
5Y-15.2%10Y-15.2%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%2.4%-7.1%
TTM-4.3%2.6%-6.9%
YOY-7.2%2.9%-10.1%
5Y-15.2%2.3%-17.5%
10Y-15.2%2.4%-17.6%

1.2. Operating Efficiency of Nyxoah.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nyxoah is operating .

  • Measures how much profit Nyxoah makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -4,823.1% means the company generated €-48.23  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nyxoah:

  • The MRQ is -4,823.1%. The company is operating very inefficient. -2
  • The TTM is -2,298.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4,823.1%TTM-2,298.4%-2,524.7%
TTM-2,298.4%YOY-2,640.4%+342.0%
TTM-2,298.4%5Y-1,646.3%-652.2%
5Y-1,646.3%10Y-1,646.3%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,823.1%10.1%-4,833.2%
TTM-2,298.4%9.8%-2,308.2%
YOY-2,640.4%10.8%-2,651.2%
5Y-1,646.3%7.9%-1,654.2%
10Y-1,646.3%7.2%-1,653.5%
1.2.2. Operating Ratio

Measures how efficient Nyxoah is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 49.58 means that the operating costs are €49.58 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Nyxoah:

  • The MRQ is 49.577. The company is inefficient in keeping operating costs low. -1
  • The TTM is 23.711. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ49.577TTM23.711+25.866
TTM23.711YOY27.418-3.707
TTM23.7115Y17.043+6.668
5Y17.04310Y17.0430.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ49.5771.172+48.405
TTM23.7111.094+22.617
YOY27.4180.990+26.428
5Y17.0431.046+15.997
10Y17.0431.006+16.037

1.3. Liquidity of Nyxoah.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nyxoah is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 5.97 means the company has €5.97 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Nyxoah:

  • The MRQ is 5.965. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.929. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.965TTM8.929-2.964
TTM8.929YOY10.960-2.031
TTM8.9295Y9.045-0.116
5Y9.04510Y9.0450.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9652.529+3.436
TTM8.9292.586+6.343
YOY10.9602.402+8.558
5Y9.0452.490+6.555
10Y9.0452.359+6.686
1.3.2. Quick Ratio

Measures if Nyxoah is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.41 means the company can pay off €1.41 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nyxoah:

  • The MRQ is 1.410. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.056. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.410TTM2.056-0.646
TTM2.056YOY0.215+1.841
TTM2.0565Y0.919+1.137
5Y0.91910Y0.9190.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4101.102+0.308
TTM2.0561.064+0.992
YOY0.2151.119-0.904
5Y0.9191.094-0.175
10Y0.9191.026-0.107

1.4. Solvency of Nyxoah.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nyxoah assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nyxoah to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.19 means that Nyxoah assets are financed with 18.9% credit (debt) and the remaining percentage (100% - 18.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nyxoah:

  • The MRQ is 0.189. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.158. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.158+0.031
TTM0.158YOY0.188-0.030
TTM0.1585Y0.297-0.139
5Y0.29710Y0.2970.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1890.347-0.158
TTM0.1580.341-0.183
YOY0.1880.368-0.180
5Y0.2970.376-0.079
10Y0.2970.372-0.075
1.4.2. Debt to Equity Ratio

Measures if Nyxoah is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 23.3% means that company has €0.23 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nyxoah:

  • The MRQ is 0.233. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.188. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.233TTM0.188+0.045
TTM0.188YOY0.232-0.044
TTM0.1885Y0.739-0.551
5Y0.73910Y0.7390.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2330.517-0.284
TTM0.1880.520-0.332
YOY0.2320.591-0.359
5Y0.7390.628+0.111
10Y0.7390.632+0.107

2. Market Valuation of Nyxoah

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Nyxoah generates.

  • Above 15 is considered overpriced but always compare Nyxoah to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -27.34 means the investor is paying €-27.34 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nyxoah:

  • The EOD is -21.083. Company is losing money. -2
  • The MRQ is -27.337. Company is losing money. -2
  • The TTM is -52.418. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-21.083MRQ-27.337+6.254
MRQ-27.337TTM-52.418+25.080
TTM-52.418YOY-100.979+48.561
TTM-52.4185Y-61.327+8.909
5Y-61.32710Y-61.3270.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-21.08359.546-80.629
MRQ-27.33761.746-89.083
TTM-52.41885.285-137.703
YOY-100.97998.197-199.176
5Y-61.32757.263-118.590
10Y-61.32753.213-114.540
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Nyxoah.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Nyxoah:

  • The MRQ is -36.474. Very Bad. -2
  • The TTM is -60.432. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-36.474TTM-60.432+23.958
TTM-60.432YOY-115.882+55.449
TTM-60.4325Y72.953-133.385
5Y72.95310Y72.9530.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.474-0.016-36.458
TTM-60.432-0.191-60.241
YOY-115.8820.014-115.896
5Y72.9530.044+72.909
10Y72.9530.101+72.852

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nyxoah is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.28 means the investor is paying €1.28 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Nyxoah:

  • The EOD is 0.989. Very good. +2
  • The MRQ is 1.282. Good. +1
  • The TTM is 2.382. Good. +1
Trends
Current periodCompared to+/- 
EOD0.989MRQ1.282-0.293
MRQ1.282TTM2.382-1.100
TTM2.382YOY7.461-5.079
TTM2.3825Y4.942-2.560
5Y4.94210Y4.9420.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.9892.751-1.762
MRQ1.2822.850-1.568
TTM2.3823.702-1.320
YOY7.4614.453+3.008
5Y4.9423.597+1.345
10Y4.9423.186+1.756
2. Total Gains per Share

2.4. Latest News of Nyxoah

Does Nyxoah still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Nyxoah to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-09
22:30
Nyxoah Appoints Mr. Daniel Wildman to its Board of DirectorsRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nyxoah compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2000.777-126%0.264-176%0.429-147%0.429-147%
Book Value Growth--0.9631.159-17%1.674-43%1.834-48%1.834-48%
Book Value Per Share--5.1495.441-5%3.159+63%3.054+69%3.054+69%
Book Value Per Share Growth--0.9631.427-33%1.579-39%1.897-49%1.897-49%
Current Ratio--5.9658.929-33%10.960-46%9.045-34%9.045-34%
Debt To Asset Ratio--0.1890.158+20%0.188+1%0.297-36%0.297-36%
Debt To Equity Ratio--0.2330.188+24%0.232+0%0.739-68%0.739-68%
Dividend Per Share----0%-0%-0%-0%
Eps---0.241-0.246+2%-0.215-11%-0.187-23%-0.187-23%
Eps Growth--0.7490.932-20%0.906-17%0.807-7%0.807-7%
Free Cash Flow Per Share---0.502-0.400-20%-0.223-56%-0.237-53%-0.237-53%
Free Cash Flow Per Share Growth--0.4990.857-42%0.290+72%0.517-3%0.517-3%
Free Cash Flow To Equity Per Share---0.517-0.036-93%0.605-185%0.410-226%0.410-226%
Free Cash Flow To Equity Per Share Growth--0.4910.480+2%2.256-78%3.735-87%3.735-87%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--24.130--------
Intrinsic Value_10Y_min--19.443--------
Intrinsic Value_1Y_max---1.019--------
Intrinsic Value_1Y_min---1.003--------
Intrinsic Value_3Y_max---0.441--------
Intrinsic Value_3Y_min---0.474--------
Intrinsic Value_5Y_max--3.293--------
Intrinsic Value_5Y_min--2.831--------
Net Profit Margin---34.286-17.739-48%-28.656-16%-15.465-55%-15.465-55%
Operating Margin---48.231-22.984-52%-26.404-45%-16.463-66%-16.463-66%
Operating Ratio--49.57723.711+109%27.418+81%17.043+191%17.043+191%
Pb Ratio0.989-30%1.2822.382-46%7.461-83%4.942-74%4.942-74%
Pe Ratio-21.083+23%-27.337-52.418+92%-100.979+269%-61.327+124%-61.327+124%
Peg Ratio---36.474-60.432+66%-115.882+218%72.953-150%72.953-150%
Price Per Share5.090-30%6.60013.135-50%21.575-69%13.203-50%13.203-50%
Price To Total Gains Ratio-25.422+23%-32.963-40.305+22%-52.179+58%-46.242+40%-46.242+40%
Profit Growth--0.7491.055-29%0.786-5%0.799-6%0.799-6%
Quick Ratio--1.4102.056-31%0.215+555%0.919+54%0.919+54%
Return On Assets---0.038-0.036-5%-0.058+53%-0.067+76%-0.067+76%
Return On Equity---0.047-0.043-8%-0.072+54%-0.152+224%-0.152+224%
Revenue Growth--0.1951.325-85%1.057-82%1.236-84%1.236-84%
Total Gains Per Share---0.2000.777-126%0.264-176%0.429-147%0.429-147%
Total Gains Per Share Growth--0.8161.746-53%-0.762+193%0.522+56%0.522+56%
Usd Book Value--144407564.000152620086.300-5%97387204.500+48%88603324.400+63%88603324.400+63%
Usd Book Value Change Per Share---0.2170.843-126%0.287-176%0.466-147%0.466-147%
Usd Book Value Per Share--5.5875.905-5%3.428+63%3.315+69%3.315+69%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.262-0.267+2%-0.233-11%-0.203-23%-0.203-23%
Usd Free Cash Flow---14076129.200-11209844.700-20%-7184024.000-49%-6556687.967-53%-6556687.967-53%
Usd Free Cash Flow Per Share---0.545-0.434-20%-0.242-56%-0.257-53%-0.257-53%
Usd Free Cash Flow To Equity Per Share---0.561-0.039-93%0.657-185%0.445-226%0.445-226%
Usd Price Per Share5.524-30%7.16214.254-50%23.413-69%14.328-50%14.328-50%
Usd Profit---6771648.000-6559762.700-3%-6921134.300+2%-5393308.350-20%-5393308.350-20%
Usd Revenue--197506.400562133.600-65%151385.400+30%237839.667-17%237839.667-17%
Usd Total Gains Per Share---0.2170.843-126%0.287-176%0.466-147%0.466-147%
 EOD+3 -2MRQTTM+6 -33YOY+13 -265Y+13 -2610Y+13 -26

3.2. Fundamental Score

Let's check the fundamental score of Nyxoah based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.083
Price to Book Ratio (EOD)Between0-10.989
Net Profit Margin (MRQ)Greater than0-34.286
Operating Margin (MRQ)Greater than0-48.231
Quick Ratio (MRQ)Greater than11.410
Current Ratio (MRQ)Greater than15.965
Debt to Asset Ratio (MRQ)Less than10.189
Debt to Equity Ratio (MRQ)Less than10.233
Return on Equity (MRQ)Greater than0.15-0.047
Return on Assets (MRQ)Greater than0.05-0.038
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Nyxoah based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.061
Ma 20Greater thanMa 505.259
Ma 50Greater thanMa 1005.294
Ma 100Greater thanMa 2005.869
OpenGreater thanClose5.180
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets164,070
Total Liabilities31,000
Total Stockholder Equity133,070
 As reported
Total Liabilities 31,000
Total Stockholder Equity+ 133,070
Total Assets = 164,070

Assets

Total Assets164,070
Total Current Assets119,342
Long-term Assets119,342
Total Current Assets
Cash And Cash Equivalents 89,877
Short-term Investments 25,505
Net Receivables 2,713
Inventory 594
Other Current Assets 653
Total Current Assets  (as reported)119,342
Total Current Assets  (calculated)119,342
+/-0
Long-term Assets
Property Plant Equipment 5,629
Intangible Assets 36,488
Long-term Assets  (as reported)44,728
Long-term Assets  (calculated)42,117
+/- 2,611

Liabilities & Shareholders' Equity

Total Current Liabilities20,007
Long-term Liabilities10,993
Total Stockholder Equity133,070
Total Current Liabilities
Short Long Term Debt 656
Accounts payable 5,346
Other Current Liabilities 8,931
Total Current Liabilities  (as reported)20,007
Total Current Liabilities  (calculated)14,933
+/- 5,074
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,553
Other Liabilities 127
Long-term Liabilities  (as reported)10,993
Long-term Liabilities  (calculated)3,680
+/- 7,313
Total Stockholder Equity
Common Stock4,440
Other Stockholders Equity 5,413
Total Stockholder Equity (as reported)133,070
Total Stockholder Equity (calculated)9,853
+/- 123,217
Other
Capital Stock4,440
Common Stock Shares Outstanding 25,846
Net Invested Capital 141,761
Net Tangible Assets 132,553
Net Working Capital 99,335



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
15,195
0
38,167
0
114,080
110,650
108,409
0
170,830
165,974
166,882
164,070
164,070166,882165,974170,8300108,409110,650114,080038,167015,1950
   > Total Current Assets 
7,974
7,974
27,125
27,125
94,108
94,108
89,261
84,437
140,060
140,060
131,552
127,182
119,342
119,342127,182131,552140,060140,06084,43789,26194,10894,10827,12527,1257,9747,974
       Cash And Cash Equivalents 
0
5,855
0
23,880
0
92,300
86,207
79,171
0
135,509
82,787
75,602
89,877
89,87775,60282,787135,509079,17186,20792,300023,88005,8550
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
45,041
47,717
25,505
25,50547,71745,0410000000000
       Net Receivables 
2,108
2,108
2,458
2,458
1,644
1,644
1,884
2,129
2,512
2,512
2,226
2,483
2,713
2,7132,4832,2262,5122,5122,1291,8841,6441,6442,4582,4582,1082,108
       Other Current Assets 
0
0
765
765
109
109
915
2,916
1,693
1,693
1,197
874
653
6538741,1971,6931,6932,91691510910976576500
   > Long-term Assets 
0
7,221
0
11,042
0
19,972
21,389
23,972
0
30,770
34,422
39,700
44,728
44,72839,70034,42230,770023,97221,38919,972011,04207,2210
       Property Plant Equipment 
1,388
1,388
1,671
1,671
3,996
3,996
4,010
4,504
5,238
5,238
5,202
5,521
5,629
5,6295,5215,2025,2385,2384,5044,0103,9963,9961,6711,6711,3881,388
       Intangible Assets 
0
5,734
0
9,269
0
15,853
17,247
19,313
0
25,322
0
32,570
36,488
36,48832,570025,322019,31317,24715,85309,26905,7340
> Total Liabilities 
0
11,482
0
12,756
0
16,890
19,147
23,273
0
22,208
23,360
28,637
31,000
31,00028,63723,36022,208023,27319,14716,890012,756011,4820
   > Total Current Liabilities 
3,571
3,571
4,500
4,500
6,402
6,402
8,616
12,647
11,572
11,572
12,642
17,565
20,007
20,00717,56512,64211,57211,57212,6478,6166,4026,4024,5004,5003,5713,571
       Short Long Term Debt 
0
378
0
1,382
0
616
658
758
0
554
598
661
656
656661598554075865861601,38203780
       Accounts payable 
1,385
1,385
1,343
1,343
1,190
1,190
2,802
4,967
3,995
3,995
3,401
4,301
5,346
5,3464,3013,4013,9953,9954,9672,8021,1901,1901,3431,3431,3851,385
       Other Current Liabilities 
157
157
1,364
1,364
2,121
2,121
2,770
4,276
3,593
3,593
8,044
7,624
8,931
8,9317,6248,0443,5933,5934,2762,7702,1212,1211,3641,364157157
   > Long-term Liabilities 
0
7,911
0
8,256
0
10,488
10,531
10,626
0
10,636
10,718
11,072
10,993
10,99311,07210,71810,636010,62610,53110,48808,25607,9110
       Capital Lease Obligations Min Short Term Debt
0
1,075
0
1,306
0
3,317
3,212
3,169
0
3,319
3,263
3,531
3,553
3,5533,5313,2633,31903,1693,2123,31701,30601,0750
       Other Liabilities 
30
30
30
30
37
37
37
37
97
97
102
124
127
12712410297973737373730303030
> Total Stockholder Equity
0
3,713
0
25,411
0
97,190
91,503
85,136
0
148,622
142,614
138,245
133,070
133,070138,245142,614148,622085,13691,50397,190025,41103,7130
   Common Stock
2,481
2,481
2,917
2,917
3,796
3,796
3,798
3,808
4,427
4,427
4,432
4,438
4,440
4,4404,4384,4324,4274,4273,8083,7983,7963,7962,9172,9172,4812,481
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
627
627
1,011
1,011
2,799
2,799
2,729
2,991
3,329
3,329
3,888
4,499
5,413
5,4134,4993,8883,3293,3292,9912,7292,7992,7991,0111,011627627



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue852
Cost of Revenue-303
Gross Profit549549
 
Operating Income (+$)
Gross Profit549
Operating Expense-27,094
Operating Income-26,242-26,545
 
Operating Expense (+$)
Research Development6,567
Selling General Administrative19,249
Selling And Marketing Expenses-
Operating Expense27,09425,816
 
Net Interest Income (+$)
Interest Income1
Interest Expense-386
Net Interest Income-1,597-385
 
Pretax Income (+$)
Operating Income-26,242
Net Interest Income-1,597
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-24,639-29,442
EBIT - interestExpense = -26,628
-24,639
-27,233
Interest Expense386
Earnings Before Interest and Taxes (ebit)-26,242-24,253
Earnings Before Interest and Taxes (ebitda)-22,591
 
After tax Income (+$)
Income Before Tax-24,639
Tax Provision-2,980
Net Income From Continuing Ops-27,619-27,619
Net Income-27,619
Net Income Applicable To Common Shares-27,619
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses265
Total Other Income/Expenses Net3,2001,597
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SBFM.NASDAQ
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBFM.NASDAQ.

SBFM.NASDAQ Daily Candlestick Chart
SANW.NASDAQ
2 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of SANW.NASDAQ.

SANW.NASDAQ Daily Candlestick Chart
RZB.NYSE
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RZB.NYSE.

RZB.NYSE Daily Candlestick Chart
RYU.NYSE ARC
3 minutes ago

I found you a Golden Cross on the daily chart of RYU.NYSE ARC.

RYU.NYSE ARC Daily Candlestick Chart
RRGB.NASDAQ
5 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RRGB.NASDAQ.

RRGB.NASDAQ Daily Candlestick Chart
RNAZ.NASDAQ
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RNAZ.NASDAQ.

RNAZ.NASDAQ Daily Candlestick Chart
SBITOP.INDX
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBITOP.INDX.

SBITOP.INDX Daily Candlestick Chart
BETXT.INDX
10 minutes ago

I found you a Golden Cross on the daily chart of BETXT.INDX.

BETXT.INDX Daily Candlestick Chart
RGF.NASDAQ
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RGF.NASDAQ.

RGF.NASDAQ Daily Candlestick Chart
REED.NASDAQ
14 minutes ago

I found you a Golden Cross on the daily chart of REED.NASDAQ.

REED.NASDAQ Daily Candlestick Chart
RCUS.NYSE
14 minutes ago

I found you a Death Cross on the daily chart of RCUS.NYSE.

RCUS.NYSE Daily Candlestick Chart
RAIN.NASDAQ
18 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RAIN.NASDAQ.

RAIN.NASDAQ Daily Candlestick Chart
PZZA.NASDAQ
21 minutes ago

I found you a Golden Cross on the daily chart of PZZA.NASDAQ.

PZZA.NASDAQ Daily Candlestick Chart
PTLC.BATS
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PTLC.BATS.

PTLC.BATS Daily Candlestick Chart
WWY1.F
32 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of WWY1.F.

WWY1.F Daily Candlestick Chart
W7V.F
35 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of W7V.F.

W7V.F Daily Candlestick Chart
UZQ.F
36 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UZQ.F.

UZQ.F Daily Candlestick Chart
TG1N.F
39 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TG1N.F.

TG1N.F Daily Candlestick Chart
SZL.F
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SZL.F.

SZL.F Daily Candlestick Chart
S1K2.F
43 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of S1K2.F.

S1K2.F Daily Candlestick Chart
RYQ.F
43 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RYQ.F.

RYQ.F Daily Candlestick Chart
RHRD.F
44 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of RHRD.F.

RHRD.F Daily Candlestick Chart
PX0.F
45 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PX0.F.

PX0.F Daily Candlestick Chart
PH6.F
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PH6.F.

PH6.F Daily Candlestick Chart
OCD1.F
48 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of OCD1.F.

OCD1.F Daily Candlestick Chart